Actually, drugs affecting D2R/β-arrestin interaction demonstrate antipsychotic effects in animal models of schizophrenia (Park et al., 2016), revealing alternative therapeutic strategies, downstream to D2R. This evidence concerns the gene DRD2 and schizophrenia.